The "Healthcare/Pharmaceutical Asset Management Market [Wi-Fi RTLS‚ RFID (Tags – Active & Passive‚ Software)‚ IR‚ Ultrasound‚ Equipment & Patient Tracking‚ Staff Safety‚ Temperature & Humidity Monitoring‚ Drug Counterfeit] - Global Forecast to 2017 " analyzes and studies the major market drivers‚ restraints‚ and opportunities in North America‚ Latin America‚ Europe‚ Asia‚ and Rest of the World. Browse 133 market data tables with 13 figures spread through 279 pages and in-depth TOC on Healthcare/Pharmaceutical
Premium North America RFID
EMPLOYEE SAFETY IN ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED‚ ALTHAUR UNIT‚ CHENNAI CHAPTER – 1 INTRODUCTION Human resource is a valuable resource‚ or asset of every organization without the human resource‚ no organization can accomplish the organization goal. In an industrial sector‚ there is a lot of chance and various factors which may create physical hazards and injuries. Occupational safety‚ healthy‚ industrial hygiene is the legal provision
Premium Occupational safety and health
recruitment and selection play a crucial role for company’ success. This case study assesses HR recruitment and practices of Novellas Healthcare firm; a mid-size consultancy company active in Healthcare and Pharmaceutical industry. A structured interview questionnaire combined with company’ website review and literature researchs‚ allowed us to gain an insight
Premium Management Employment Human resource management
Ninety Day Business Plan For Auxilium MSC 30 Day: * Begin home study. * Attend Training. * Continuously study and master product info and clinical trials. * Review current accounts and analyze sales data across the territory. * Identify Urologists‚ Endocrinologist‚ Internal Medicine & Family Practice Physicians within territory (Including Nurse Practitioners & Physician Assistants). Also target local pharmacies within various areas of the territory. * Meet
Premium Physician Medical prescription Decision making
ARE BRANDING STRATEGIES IN THE PHARMACEUTICAL INDUSTRY VERSUS FAST MOVING CONSUMER GOODS? Abstract The objective of this paper is to analyse the branding strategies used currently in the pharmaceutical industry and compare it to the best practices in Fast Moving Consumer goods. First the authors review the differences in the way branding is defined and organised in pharmaceuticals versus FMCG and identify why branding could be leveraged in the pharmaceutical industry to help it return to
Premium Brand Brand management Branding
Rhetorical Analysis: Pharmaceutical Innovation In Joel Lexchin’s article “Pharmaceutical innovation: Can we live forever? A commentary on Schnittker and Karandinos” he addresses the article made by Schnittker and Karandinos about the progression of pharmaceuticals and whether or not we have advanced enough to significantly increase our life expectancy. Lexchin uses a plethora of rhetoric to persuade the reader into believing his argument‚ mostly relying upon logos‚ chiefly facts‚ to appeal to
Premium Life expectancy Mortality rate Medicine
Questionnaire For Consumers : Name ____________________________ Age ____________________________ Sex ____________________________ Address ____________________________ Q. Are you aware of various products of various brands ? (a) Yes (b) No Q. Do you use OTC segment products of different brand? (a) Yes (b) No Q. Which brand you found reliable in OTC segment (a) Cipla (b) Ranbaxy (c) Ind-Swift (d) Other Q. Do advertisement
Premium Marketing Suggestion Consumer
resulting in successful IPOs. We expect the optimism to percolate further into companies with novel technology platforms and targets. For more details on the trend in drug approvals‚ upcoming milestones and M&A in coming years please see Global Pharmaceutical and Biotechnology Outlook 2014 :Rising Stars Nquire Before Buying @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=274681 . Table of Contents Macro Analysis • Drug Approval in 2013 • PERFORMANCE OF IPOS: 2013 • DRUG LAUNCHES:
Premium Drug discovery Clinical trial Orphan drug
strategy? Anticipating sustainability for generic pharmaceutical industry Journal of Medical Marketing 2014‚ Vol. 14(2–3) 81–90 ! The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1745790414556563 mmj.sagepub.com Fereshteh Barei1 and Claude Le Pen2 Abstract The repercussions of product innovation crisis in big pharma drive the generic pharmaceutical industry to lower its dependence on original pharmaceutical industry. Moreover‚ an important change is happening
Premium Drug development Pharmaceutical industry Drug discovery
Discuss issues associated with pharmaceutical transnational corporations regarding research‚ production and distribution of drugs. (15 marks) An example of an issue with pharmaceutical drug corporations is the ethics associated with researching the drugs. For example‚ Pfizer caused an international scandal when they illegally tested a drug to cure meningitis in Nigeria. 11 children died due to not enough research into the effects of the drug on children. This is an ethical issue‚ as if Pfizer
Premium Pharmacology Pharmaceutical drug Medicine